Cargando…

Does atenolol differ from other β-adrenergic blockers?

BACKGROUND: A recent meta-analysis of drug effects in patients with hypertension claims that all β-adrenergic blockers are equally effective but less so than other antihypertensive drugs. Published comparisons of the β-adrenergic blocker atenolol and non-atenolol β-adrenergic blockers indicate diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aursnes, Ivar, Osnes, Jan-Bjørn, Tvete, Ingunn Fride, Gåsemyr, Jørund, Natvig, Bent
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876203/ https://www.ncbi.nlm.nih.gov/pubmed/17488499 http://dx.doi.org/10.1186/1472-6904-7-4

Ejemplares similares

Even more suicide attempts in clinical trials with paroxetine randomised against placebo
por: Aursnes, Ivar, et al.
Publicado: (2006)

Suicide attempts in clinical trials with paroxetine randomised against placebo
por: Aursnes, Ivar, et al.
Publicado: (2005)

Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis
por: Tvete, Ingunn Fride, et al.
Publicado: (2015)

Correction: Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis
por: Tvete, Ingunn Fride, et al.
Publicado: (2016)

Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis
por: Binde, Caroline D., et al.
Publicado: (2020)

A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing
por: Tvete, Ingunn Fride, et al.
Publicado: (2013)

Risk factors for excessive benzodiazepine use in a working age population: a nationwide 5-year survey in Norway
por: Fride Tvete, Ingunn, et al.
Publicado: (2015)

Mental Health and Disability Pension Onset: Changes in Consumption of Antianxiety and Hypnotic Drugs
por: Tvete, Ingunn Fride, et al.
Publicado: (2018)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Rakesh, K. B., et al.
Publicado: (2016)

Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
por: Seebauer, Caroline T., et al.
Publicado: (2022)

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
por: Halvorsen, Sigrun, et al.
Publicado: (2017)

Change in mRNA Expression after Atenolol, a Beta-adrenergic Receptor Antagonist and Association with Pharmacological Response
por: Kohli, Utkarsh, et al.
Publicado: (2009)

A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure
por: Zhang, Xiaojian, et al.
Publicado: (2016)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury
por: Nurlu Temel, Esra, et al.
Publicado: (2023)

Fixed drug eruption induced by atenolol
por: Belhadjali, H, et al.
Publicado: (2009)

Preparation and Evaluation of Buccoadhesive Films of Atenolol
por: Satishbabu, B. K., et al.
Publicado: (2008)

A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas
por: Zhao, Ze-Liang, et al.
Publicado: (2021)

Can beta-adrenergic blockers be used in the treatment of COVID-19?
por: Vasanthakumar, Natesan
Publicado: (2020)

Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy
por: Reddy, Sushma, et al.
Publicado: (2015)

Regulation of Cisplatin Resistance in Lung Cancer Cells by Nicotine, BDNF, and a β-Adrenergic Receptor Blocker
por: Ray, Ravel, et al.
Publicado: (2022)

New device and technique for lung deflation in bronchial blocker
por: Lai, Hou-Chuan, et al.
Publicado: (2019)

β1 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to β-Blocker Therapy and Prognosis
por: Liu, Wen-Nan, et al.
Publicado: (2012)

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)

Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review
por: Brewster, Lizzy M, et al.
Publicado: (2013)

Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
por: Wikoff, William R., et al.
Publicado: (2013)

Formulation and Evaluation of Mouth Disintegrating Tablets of Atenolol and Atorvastatin
por: Sarfraz, R. M., et al.
Publicado: (2015)

Oxidative Tea Polyphenols Greatly Inhibit the Absorption of Atenolol
por: Shan, Yun, et al.
Publicado: (2016)

Revisiting atenolol as a low passive permeability marker
por: Chen, Xiaomei, et al.
Publicado: (2017)

A Case of Life-threatening Amlodipine and Atenolol Overdose
por: Tale, Sudheer, et al.
Publicado: (2019)

The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
por: Frost, Charles, et al.
Publicado: (2017)

The Effect of pH on Atenolol/Nanofiltration Membranes Affinity
por: Soares, Elisa Veridiani, et al.
Publicado: (2021)

Mechanisms by which angiotensin-receptor blockers increase ACE2 levels
por: Ferrario, Carlos M., et al.
Publicado: (2020)

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2016)

Enantioseparation, quantification, molecular docking and molecular dynamics study of five β-adrenergic blockers on Lux-Cellulose-2 column
por: Saleh, Ola Ahmed, et al.
Publicado: (2023)

Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients
por: Berends, Annika M. A., et al.
Publicado: (2022)

Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19
por: Zelek, Wioleta M., et al.
Publicado: (2020)

Does β-toxin Production Contribute to the Cytotoxicity of Hypervirulent Staphylococcus aureus?
por: Dupieux, Céline, et al.
Publicado: (2015)

Deficient supplies of drugs for life threatening diseases in an African community
por: Lufesi, Norman N, et al.
Publicado: (2007)

Combined verapamil and atenolol poisoning: resolution of cardiogenic shock with enoximone
por: Gallizzi, F, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_9dctvhglcag10uepbqdhkhfcpr